On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach
PD-1/PD-L1 immune checkpoint blockade for cancer therapy showed promising results in clinical studies. Further endeavors are required to enhance patient stratification, as, at present, only a small portion of patients with PD-L1-positive tumors (as determined by PD-L1 targeted immunohistochemistry;...
Bewaard in:
Hoofdauteurs: | Karsten Bamminger (Auteur), Verena Pichler (Auteur), Chrysoula Vraka (Auteur), Tina Nehring (Auteur), Katharina Pallitsch (Auteur), Barbara Lieder (Auteur), Marcus Hacker (Auteur), Wolfgang Wadsak (Auteur) |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide
door: Verena Pichler, et al.
Gepubliceerd in: (2019) -
Development and Preclinical Evaluation of [<sup>68</sup>Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression
door: Yong Huang, et al.
Gepubliceerd in: (2023) -
Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
door: Marius Ozenil, et al.
Gepubliceerd in: (2021) -
Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1
door: Marius Ozenil, et al.
Gepubliceerd in: (2020) -
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor
door: Antonia Högnäsbacka, et al.
Gepubliceerd in: (2022)